XML 37 R28.htm IDEA: XBRL DOCUMENT v3.23.1
Stock-Based Compensation (Tables)
3 Months Ended
Mar. 31, 2023
Stock-Based Compensation  
Schedule of stock-based compensation expense

Stock-based compensation expense as reflected in the Company’s condensed consolidated statements of operations and comprehensive loss was as follows:

Three months ended
March 31, 

    

2023

    

2022

(in thousands)

Research and development

$

449

$

83

General and administrative

 

1,015

 

544

Stock-based compensation expense included in operating expenses

$

1,464

$

627

Summary of stock option activity

The following is a summary of the Company’s stock option activity for the three months ended March 31, 2023:

    

    

Weighted- 

    

Weighted- average 

    

Aggregate 

average 

remaining contractual 

intrinsic value

Options

exercise price

term (in years)

(in thousands)

Outstanding at December 31, 2022

 

4,408,274

$

3.44

 

8.52

$

350

Granted

 

2,101,316

 

1.06

 

 

Exercised

(462,073)

0.49

Cancelled

(893,071)

2.64

Outstanding at March 31, 2023

 

5,154,446

 

2.87

 

7.63

$

2,819

Vested at March 31, 2023

 

2,569,967

 

2.42

 

4.17

$

1,092

Vested and expected to vest at March 31, 2023

 

5,154,446

$

2.87

 

7.63

$

2,819

The following is a summary of the Company’s stock option activity for the three months ended March 31, 2022:

    

    

Weighted- 

    

Weighted- average 

    

Aggregate 

average 

remaining contractual 

intrinsic value

Options

exercise price

term (in years)

(in thousands)

Outstanding at December 31, 2021

 

3,021,799

$

3.71

 

8.94

$

10,903

Granted

 

1,314,200

 

3.46

 

 

Exercised

(44,105)

0.43

Cancelled

(145,787)

4.10

Outstanding at March 31, 2022

 

4,146,107

 

2.55

 

9.31

$

2,529

Vested at March 31, 2022

 

760,028

 

1.37

 

8.23

$

1,188

Vested and expected to vest at March 31, 2022

 

4,146,107

$

2.55

 

9.31

$

2,529

Schedule of assumptions used in estimation of fair value

    

Three months ended March 31, 

 

2023

    

2022

 

Risk-free interest rate

 

3.67 - 4.24

%  

1.62 - 2.41

%

Volatility

 

73-74

%  

75-76

%

Dividend yield

 

0.00

%  

0.00

%

Expected term (years)

 

2-6

 

6

Summary of restricted stock units activity

The following table summarizes activity related to RSUs:

    

    

Weighted- average

grant date

Number of shares

fair value

Unvested at December 31, 2022

 

125,622

$

16.00

Granted

 

96,025

 

0.98

Vested

(12,562)

$

16.00

Unvested at March 31, 2023

 

209,085

$

9.10